Open permanent position

HTA Epidemiologist, F.Hoffman-La Roche Ltd, Basel CH

The role is located within the Evidence Synthesis team in the Modeling, Outcomes Research, Statistics, and Epidemiology Health Technology Assessment (MORSE-HTA) group, a scientific expert group in Global Pricing and Market Access (GPMA) function in Basel, Switzerland. 

The role provides strategic epidemiological evidence and insights  to support payer strategy, market access and the clinical development plan for the assigned products from Integrated Development and Commercialization Plan (IDCP)/Phase II through to launch and post-launch. You will identify and recommend data needs to enable best-in-class evidence gathering and synthesis and make critical contributions to inform the product value strategy, HTA submissions, and payer and reimbursement submissions and negotiations; ensuring payer-relevant evidence requirements are incorporated into the clinical development program. Given the nature of this position, you will be a standing or ad hoc member of various MORSE-HTA teams, the International Payer Strategy Team (IPST), the Global Payer Evidence Team (GPET), the HTA Team, and (as needed) other cross-functional teams.

In this position, you will be primarily accountable for consistently, effectively: 

•	Maximizing the value of Roche Pharma products by providing evidence synthesis expertise 
•	Assuming accountability for MORSE-HTA Evidence Synthesis deliverables for the assigned disease/therapeutic area(s), including evidence synthesis inputs into publications and external presentations  
•	Acting as a standing or ad hoc member in various internal, cross-functional teams; making critical scientific contributions and providing guidance to others in the execution of development, commercial and market access-specific strategies 
•	Identifying data needs and recommending solutions to internal partners/stakeholders to generate robust evidence 
•	Advising others on design and execution of epidemiological projects to support the product strategy and market access 
•	Conducting systematic evaluation of clinical trials, treatment and HTA guidelines
•	Analyzing  the clinical trial and observational evidence base to generate comparative efficacy, safety and quality of life data using meta-analysis and/or network meta-analysis and indirect treatment comparison
•	Supporting development and execution of payer and product value strategies, supportive internal documentation, HTA submissions, and payer and reimbursement submissions and negotiations
•	Managing external vendor relationships and deliverables 
•	Establishing and cultivating cross-functional relationships. Working collaboratively with all internal/external partners and stakeholders
•	Ensuring assigned goals and objectives are met and that assigned projects and other work are completed on time, to high standards and within budget 

Qualifications and/or experience:

•	Graduate or higher-level Degree in epidemiology, quantitative methods, economics, or a related discipline (e.g. Masters, PhD or MD)
•	3 or more years’ epidemiology experience
•	Experience designing, conducting, analyzing and interpreting systematic review, meta-analysis and network meta-analysis/indirect treatment comparisons (includes healthcare/pharmaceutical HTA related experience) is strongly preferred 
•	2 or more years’ experience in either the pharmaceutical or related industry or within a vendor organization 
•	Relevant experience in the oncology therapeutic area is preferred
•	Project and budget management experience is preferred 
•	International or global work experience is a plus 

Please respond via email for more information to: [log in to unmask]

Kind regards,
Iain Tatt

MORSE HTA Group, GPMA

You may leave the list at any time by sending the command

SIGNOFF allstat

to [log in to unmask], leaving the subject line blank.